| Serial Number | 97241251 |
| Word Mark | BASECAMP |
| Filing Date | Thursday, January 27, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 14, 2023 |
| Registration Number | 7002127 |
| Registration Date | Tuesday, March 14, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 26, 2022 |
| Pseudo Mark | BASE CAMP |
| Goods and Services | Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Pharmaceutical research and development; Product research and development; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical testing services and information in the field of cancer research and disease classification; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 1, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, May 13, 2019 |
| First Use In Commerce Date | Monday, May 13, 2019 |
| Party Name | ElevateBio, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | ElevateBio, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | ElevateBio, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Tuesday, March 14, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, March 14, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 7, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Monday, February 6, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Monday, January 9, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, January 4, 2023 | USE AMENDMENT FILED |
| Wednesday, January 4, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, October 13, 2022 | CORRECTED NOA E-MAILED |
| Wednesday, October 12, 2022 | NOTICE OF ALLOWANCE CORRECTION ENTERED |
| Wednesday, October 12, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, September 23, 2022 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Tuesday, September 20, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 26, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 26, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 6, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, June 23, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, June 2, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 2, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 2, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 11, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 11, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, May 11, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, May 9, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, February 1, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, January 31, 2022 | NEW APPLICATION ENTERED |